SCHEMBL23019882

SCHEMBL23019882

C=C1N(C)CCN1c1ccnc(F)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.36
▸ HRH4 Q9H3N8 2/20 0.36
▸ ROCK1 Q13464 3/20 0.33
▸ ALDH1A1 P00352 6/20 0.32
▸ CYP1A2 P05177 5/20 0.32
▸ CYP2D6 P10635 4/20 0.32
▸ CYP3A4 P08684 4/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ USP2 O75604 2/20 0.32
▸ HSD17B10 Q99714 4/20 0.32
▸ TSHR P16473 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ALOX15 P16050 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CLK4 Q9HAZ1 2/20 0.31
▸ CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20685738 0.81 RPS6KA5 (0.39) HRH3HRH4ROCK1ALDH1A1CYP1A2
SCHEMBL23019822 0.74 HRH4 (0.31) HRH3HRH4
SCHEMBL20685939 0.74 HRH4 (0.31) HRH3HRH4
SCHEMBL20685737 0.73 HRH3 (0.37) HRH3HRH4ROCK1ALDH1A1LMNA
SCHEMBL20685899 0.69 LCK (0.40) —
SCHEMBL14831084 0.66 IDH1 (0.47) —
SCHEMBL23019884 0.64 SMN1; SMN2 (0.56) ALDH1A1TSHRKDM4EMAPTSMN1; SMN2
SCHEMBL20685927 0.63 TRPV1 (0.36) HRH3HRH4ROCK1
SCHEMBL20685888 0.62 KMT2A (0.35) HRH3HRH4MAPTSMN1; SMN2
SCHEMBL19402116 0.62 IDH1 (0.47) HRH3HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3434674-B1 ((4-(2-OXOIMIDAZOLIDINE-1-YL)PYRIMIDIN-2-YL)AMINE DERIVATIVES AS MUTANT IDH INHIBITORS FOR TREATING CANCER SHANGHAI HAIHE PHARMACEUTICAL CO LTD (CN) 2021-02-24 — — EP disclosed
Send feedback